Stock UniverseDerived research view · source repositories remain read-only

Elicio Therapeutics, Inc. (ELTX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
22.09
Global Rank
3087
Market Cap
227.00M
Latest Close
13.26
RS Composite
28.34% · G#316

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
26.89%
3M
14.02%
6M
64.72%
1Y
63.70%
3Y
35.31%
5Y
-91.41%
10Y
-92.21%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 114.64K · 30-day average: 140.01K · Max drawdown over stored range: -98.72%

Research Snapshot

Relative Strength vs SPX

RS Composite28.34%
20D RS31.83%
60D RS3.50%
120D RS51.43%
Global RS Rank316 · 90.58% percentile
Watch+Speculative RS Rank186 · 91.13% percentile
Group ScopeWatch+Speculative
Primary RS Rank51 · 88.86% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank377 / 701
Primary Percentile46.36
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ELTX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue28.312
Revenue Growth (YoY)883.056%
Gross Profit
Operating Income-15.7211-25.4747-23.733-35.745-44.986
Free Cash Flow-16.9043-24.4644-22.833-32.76-37.155-36.968
Free Cash Flow Per Share-1.575-1.601-72.257-6.479-3.045-2.41419716156816
EPS (Diluted) GAAP-1.464183-1.727755-89.266387-6.960726-4.25289
EPS Growth
EPS Non-GAAP
Gross Margin98.4706%
Operating Margin-138.8351%
Profit Margin-192.7557%
Free Cash Flow Margin-187.2881%
Shares Outstanding (Diluted)10.73115.28030.3165.056212.20315.3128
Shares Change (YoY)172.211%42.394%-97.932%1500.081%141.346%25.484%

SEC Quarterly Fundamentals

No processed quarterly rows for ELTX.